{"id":"https://openalex.org/W4379799008","doi":"https://doi.org/10.1136/annrheumdis-2023-eular.4022","title":"POS1154 PRE-TREATMENT DIFFERENTIALLY EXPRESSED METAGENES CHARACTERIZE SYSTEMIC LUPUS PATIENTS WHO SUBSEQUENTLY ACHIEVE CLINICAL RESPONSE TO BELIMUMAB","display_name":"POS1154 PRE-TREATMENT DIFFERENTIALLY EXPRESSED METAGENES CHARACTERIZE SYSTEMIC LUPUS PATIENTS WHO SUBSEQUENTLY ACHIEVE CLINICAL RESPONSE TO BELIMUMAB","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379799008","doi":"https://doi.org/10.1136/annrheumdis-2023-eular.4022"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2023-eular.4022","doi":"https://doi.org/10.1136/annrheumdis-2023-eular.4022","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2023-eular.4022","pdf_url":"https://ard.bmj.com/content/annrheumdis/82/Suppl_1/908.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ard.bmj.com/content/annrheumdis/82/Suppl_1/908.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052053321","display_name":"Joan T. Merrill","orcid":"https://orcid.org/0000-0002-4514-2382","observed_orcids":["https://orcid.org/0000-0002-4514-2382"]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.T. Merrill","raw_affiliation_strings":["Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America","institution_ids":["https://openalex.org/I30558944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057418379","display_name":"Miles\u00a0C. Smith","orcid":"https://orcid.org/0000-0003-0651-809X","observed_orcids":["https://orcid.org/0000-0003-0651-809X"]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Smith","raw_affiliation_strings":["Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America","institution_ids":["https://openalex.org/I30558944"]}]},{"author_position":"middle","author":{"id":null,"display_name":"K. Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Thomas","raw_affiliation_strings":["Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America","institution_ids":["https://openalex.org/I30558944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014085122","display_name":"Carla J. Guthridge","orcid":"https://orcid.org/0000-0003-2219-7097","observed_orcids":["https://orcid.org/0000-0003-2219-7097"]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Guthridge","raw_affiliation_strings":["Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America","institution_ids":["https://openalex.org/I30558944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108336042","display_name":"Nicol\u00e1s Dom\u00ednguez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Dominguez","raw_affiliation_strings":["Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America","institution_ids":["https://openalex.org/I30558944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046774559","display_name":"Susan Macwana","orcid":"https://orcid.org/0009-0005-0007-0206","observed_orcids":["https://orcid.org/0009-0005-0007-0206"]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Macwana","raw_affiliation_strings":["Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America","institution_ids":["https://openalex.org/I30558944"]}]},{"author_position":"middle","author":{"id":null,"display_name":"W. Dejager","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Dejager","raw_affiliation_strings":["Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America","institution_ids":["https://openalex.org/I30558944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024269575","display_name":"Stan Kamp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Kamp","raw_affiliation_strings":["Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America","institution_ids":["https://openalex.org/I30558944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031271622","display_name":"Cristina Arriens","orcid":"https://orcid.org/0000-0002-9546-1664","observed_orcids":["https://orcid.org/0000-0002-9546-1664"]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Arriens","raw_affiliation_strings":["Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America","institution_ids":["https://openalex.org/I30558944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050355963","display_name":"B. Parrish","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Parrish","raw_affiliation_strings":["Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America","institution_ids":["https://openalex.org/I30558944"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088206527","display_name":"Judith A. James","orcid":"https://orcid.org/0000-0002-9574-7355","observed_orcids":["https://orcid.org/0000-0002-9574-7355"]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.A. James","raw_affiliation_strings":["Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America","institution_ids":["https://openalex.org/I30558944"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I30558944"],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":null,"first_page":"908","last_page":"909"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9980000257492065},{"id":"https://openalex.org/keywords/belimumab","display_name":"belimumab","score":1.0},{"id":"https://openalex.org/keywords/b-lymphocyte-stimulator","display_name":"B lymphocyte stimulator","score":0.7139999866485596},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.6549999713897705},{"id":"https://openalex.org/keywords/metagenes","display_name":"metagenes","score":0.7360000014305115},{"id":"https://openalex.org/keywords/differentially-expressed-genes","display_name":"differentially expressed genes","score":0.9580000042915344},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.6850000023841858},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.35899999737739563},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.4230000078678131},{"id":"https://openalex.org/keywords/disease-flares","display_name":"disease flares","score":0.550000011920929},{"id":"https://openalex.org/keywords/sle-responder-index","display_name":"SLE Responder Index","score":0.7279999852180481},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.35499998927116394},{"id":"https://openalex.org/keywords/immunotherapy-response-prediction","display_name":"immunotherapy response prediction","score":0.34299999475479126},{"id":"https://openalex.org/keywords/rna-sequencing","display_name":"RNA sequencing","score":0.6069999933242798},{"id":"https://openalex.org/keywords/principal-component-analysis","display_name":"principal component analysis","score":0.6190000176429749}],"concepts":[{"id":"https://openalex.org/C2781205201","wikidata":"https://www.wikidata.org/wiki/Q1996249","display_name":"Belimumab","level":5,"score":0.9231223464012146},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8851445317268372},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5304179787635803},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.5177704095840454},{"id":"https://openalex.org/C2775915377","wikidata":"https://www.wikidata.org/wiki/Q188297","display_name":"Lupus erythematosus","level":3,"score":0.4111339747905731},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.27830544114112854},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2635842561721802},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2501378059387207},{"id":"https://openalex.org/C170286685","wikidata":"https://www.wikidata.org/wiki/Q409346","display_name":"B-cell activating factor","level":4,"score":0.15294599533081055},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.10778352618217468}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/annrheumdis-2023-eular.4022","doi":"https://doi.org/10.1136/annrheumdis-2023-eular.4022","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2023-eular.4022","pdf_url":"https://ard.bmj.com/content/annrheumdis/82/Suppl_1/908.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2023-eular.4022","doi":"https://doi.org/10.1136/annrheumdis-2023-eular.4022","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2023-eular.4022","pdf_url":"https://ard.bmj.com/content/annrheumdis/82/Suppl_1/908.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4379799008.pdf","grobid_xml":"https://content.openalex.org/works/W4379799008.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4404135424","https://openalex.org/W4399482327","https://openalex.org/W4307842918","https://openalex.org/W4407181497","https://openalex.org/W4310128071","https://openalex.org/W4400932505","https://openalex.org/W4399484427","https://openalex.org/W4379648591","https://openalex.org/W4283593705","https://openalex.org/W4411432015"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2023-06-09T00:00:00"}